1,3,4,6,7,11B-HEXAHYDRO-9,10-DIHYDROXY-3-(2-METHYLPROPYL)-2H-BENZO(A)QUINOLIZIN-2-ONE, REL-(3R,11BS)-
UNII Y2R8ZQ7CMT
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3,4,6,7,11b-hexahydro-9,10-dihydroxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-one, Rel-(3r,11bs)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y2R8ZQ7CMT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H23NO3 HKXSWCIZVQFEQQ-GXTWGEPZSA-N;HKXSWCIZVQFEQQ-OCCSQVGLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3,4,6,7,11b-hexahydro-9,10-dihydroxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-one, Rel-(3r,11bs)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.